Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma. - Wikidata - awgldk - TriplyDB

Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma.

Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma.

http://www.wikidata.org/entity/Q42575965

about

Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.High expression of PD-1 ligands is associated with kataegis mutational signature and APOBEC3 alterations.The evolving genomic landscape of urothelial carcinoma.Recent progress in immunotherapy for urological cancer.Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism.APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution.Viral subversion of APOBEC3s: Lessons for anti-tumor immunity and tumor immunotherapy.Detection and genomic characterization of a mammary-like adenocarcinoma.Correlation of gene expression and associated mutation profiles of APOBEC3A, APOBEC3B, REV1, UNG, and FHIT with chemosensitivity of cancer cell lines to drug treatment.DNA repair defects and implications for immunotherapy

P2860

Q37593573-A72B24B4-29EA-4DF4-9F4A-D3C7DCB66BA6 Q38839124-37BAB07E-7C78-4621-B186-C0F3D61E19A3 Q39124491-A964B0A0-C98B-46BB-BE17-7F82DEE6FDFF Q39388043-98C4E8E7-0D01-489B-B8F0-955D788D8941 Q39459198-626B07CE-7E1F-4ED8-BFAD-5DF3882612A8 Q40063761-4B386C06-1B5E-4A5C-8DA0-F145D73CF905 Q47555165-6F6C21B8-A412-4D1A-A16E-43B4FA294902 Q47568875-6179143D-DF61-48D2-9E1F-D11646CE57F8 Q47846945-5FC66A20-27E0-4F27-B2EA-39DA764AD47A Q52719995-691F0D39-0090-4005-9E17-3C2DD8F5C2B0 Q57057014-6E676DC5-75A2-4AAA-B04F-883AC50C134D

P2860

Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma.

http://www.wikidata.org/entity/Q42575965

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Correlation of Apobec Mrna Exp ...... ssion in Urothelial Carcinoma.

@en

Correlation of Apobec Mrna Exp ...... ssion in Urothelial Carcinoma.

@nl

type

label

Correlation of Apobec Mrna Exp ...... ssion in Urothelial Carcinoma.

@en

Correlation of Apobec Mrna Exp ...... ssion in Urothelial Carcinoma.

@nl

prefLabel

Correlation of Apobec Mrna Exp ...... ssion in Urothelial Carcinoma.

@en

Correlation of Apobec Mrna Exp ...... ssion in Urothelial Carcinoma.

@nl

P1433

Q42575965-849765A7-3AF7-4519-97CE-4DAE85E70A69

P1476

Q42575965-D9EECE80-6F5B-4DF6-BD1E-6F8EFFEEF13E

P2093

Q42575965-2B7DA2EE-0FD1-4167-AC2B-483A9C7BB8F0

Q42575965-4671493D-2F5D-4575-9E90-EF26CBF51F13

Q42575965-6E2F679E-B2F8-4029-889A-87D7C5B17790

Q42575965-B3F58D13-9912-455E-8071-7B7C8624E5C7

Q42575965-B8E1725A-CA12-4DDC-8919-A8D5573E2BF4

Q42575965-E296AECC-7F3A-4788-A960-97E888C90765

Q42575965-EEE54F4D-3716-4383-929A-FC78BAFCDD04

Q42575965-FB046E32-CCA9-47D9-847B-716B1959CB89

P2860

Q42575965-04C2A000-A52C-47FB-B2A4-F7A7FE270E75

Q42575965-0AE88970-17FC-4A8F-8073-1449987CADC6

Q42575965-0F42B70E-8822-480C-A3A2-E07F455883AC

Q42575965-0FD6B8E6-BB40-4535-B56E-D6D14A4FAA30

Q42575965-10DF4F42-F71C-4485-8B5C-7EE55B9624A3

Q42575965-1D686B20-DEE1-4F57-8142-B73AE4CE9CEF

Q42575965-2E12ABA5-C4FA-45A5-B4D2-F8CE392FF9DE

Q42575965-322528D7-6EA2-42F0-AB16-8E566B4A8F2E

Q42575965-32918832-70A9-41FB-A555-427A5DB2FCEB

Q42575965-37FAC7FC-30FB-465C-ABA6-5BF59B09A53D

P2888

Q42575965-0FB2919C-93F6-46EF-B9A3-F94D4566C370

P304

Q42575965-C83E9AAC-47A8-4996-9F55-902CBB7A0B90

P31

Q42575965-394446B4-D979-46C6-9135-3E5AA26668F2

P356

Q42575965-FC5E53AE-DC33-4FAF-BB71-B6B7616ECDA5

P407

Q42575965-CB6896D1-A78C-44D2-AFEE-78BEAF7EC466

P478

Q42575965-34C1C044-BA89-4704-8607-FC1FCD402EA3

P577

Q42575965-AE9719A7-6FF7-414C-BBF3-F51FD0EDF21A

P698

Q42575965-F3D01248-BDA5-4AFF-998A-593E8E14A1D0

P932

Q42575965-2C412897-4799-4353-8948-563153D5E5E6

P356

P1433

Scientific Reports

P1476

Correlation of Apobec Mrna Exp ...... ssion in Urothelial Carcinoma.

@en

P2093

Gordon J Freeman

http://www.w3.org/2001/XMLSchema#string

Joaquim Bellmunt

http://www.w3.org/2001/XMLSchema#string

Jonathan Rosenberg

http://www.w3.org/2001/XMLSchema#string

Lillian Werner

http://www.w3.org/2001/XMLSchema#string

Marcella Callea

http://www.w3.org/2001/XMLSchema#string

Sabina Signoretti

http://www.w3.org/2001/XMLSchema#string

Stephanie A Mullane

http://www.w3.org/2001/XMLSchema#string

Toni K Choueiri

http://www.w3.org/2001/XMLSchema#string

P2860

Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1

Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Mutational processes molding the genomes of 21 breast cancers

Comprehensive molecular portraits of human breast tumours

An immunologic portrait of cancer

Cancer statistics, 2015

Comprehensive molecular characterization of gastric adenocarcinoma

Hypermutation in human cancer genomes: footprints and mechanisms

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

P2888

P304

27702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP27702

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27283319

http://www.w3.org/2001/XMLSchema#string

P932

4901342

http://www.w3.org/2001/XMLSchema#string